Biome Australia Limited
Biome Australia Limited Fundamental Analysis
Biome Australia Limited (BIO.AX) shows moderate financial fundamentals with a PE ratio of 88.79, profit margin of 4.36%, and ROE of 17.85%. The company generates $0.0B in annual revenue with strong year-over-year growth of 79.79%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 67.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze BIO.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakBIO.AX struggles to generate sufficient returns from assets.
Valuation Score
ModerateBIO.AX shows balanced valuation metrics.
Growth Score
ExcellentBIO.AX delivers strong and consistent growth momentum.
Financial Health Score
ExcellentBIO.AX maintains a strong and stable balance sheet.
Profitability Score
ModerateBIO.AX maintains healthy but balanced margins.
Key Financial Metrics
Is BIO.AX Expensive or Cheap?
P/E Ratio
BIO.AX trades at 88.79 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BIO.AX's PEG of 0.24 indicates potential undervaluation.
Price to Book
The market values Biome Australia Limited at 14.04 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 113.22 times EBITDA. This signals the market has high growth expectations.
How Well Does BIO.AX Make Money?
Net Profit Margin
For every $100 in sales, Biome Australia Limited keeps $4.36 as profit after all expenses.
Operating Margin
Core operations generate 3.33 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.85 in profit for every $100 of shareholder equity.
ROA
Biome Australia Limited generates $7.78 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Biome Australia Limited generates limited operating cash flow of $393.82K, signaling weaker underlying cash strength.
Free Cash Flow
Biome Australia Limited generates weak or negative free cash flow of $358.45K, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
BIO.AX converts 0.42% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
88.79
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.24
vs 25 benchmark
P/B Ratio
Price to book value ratio
14.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.90
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.40
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.001
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How BIO.AX Stacks Against Its Sector Peers
| Metric | BIO.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 88.79 | 28.25 | Worse (Expensive) |
| ROE | 17.85% | 780.00% | Weak |
| Net Margin | 4.36% | -20122.00% (disorted) | Weak |
| Debt/Equity | 0.40 | 0.30 | Weak (High Leverage) |
| Current Ratio | 2.00 | 4.66 | Strong Liquidity |
| ROA | 7.78% | -14687.00% (disorted) | Weak |
BIO.AX outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Biome Australia Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
3133.45%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
20.23%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
92.62%
Industry Style: Defensive, Growth, Innovation
High Growth